Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine + Gemcitabine in Pancreatic Cancer
NCT00078975Phase 2Completed
- Sponsor
- University Health Network
- Start
- Apr 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triapine in pancreatic adenocarcinoma (PDAC), sponsored by University Health Network. Primary endpoints: Objective Response Rate and 6-month Progression-Free Disease. Started Apr 2004; status: completed.
02
Drugs
triapine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00078975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078975.